ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

March 2021, Vol 157, No. 3, Pages 264-364

Viewpoint

Resisting Racism in Dermatology: A Call to Action

Abstract Full Text
JAMA Dermatol. 2021;157(3):267-268. doi:10.1001/jamadermatol.2020.5029

This Viewpoint discusses how dermatologists can work together to dismantle structural racism in dermatology.

Editorial

Topical Corticosteroids and Glucocorticoid-Induced Osteoporosis—Cumulative Dose and Duration Matter

Abstract Full Text
JAMA Dermatol. 2021;157(3):269-270. doi:10.1001/jamadermatol.2020.4967

Shared Decision-making in Dermatologic Care: A Call for More Training and Resources

Abstract Full Text
JAMA Dermatol. 2021;157(3):271-272. doi:10.1001/jamadermatol.2020.5360
Original Investigation

Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures

Abstract Full Text
free access has audio
JAMA Dermatol. 2021;157(3):275-282. doi:10.1001/jamadermatol.2020.4968

This nationwide cohort study examines the association between cumulative exposure to potent and very potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fracture among adults in Denmark.

The Risk of Anal Carcinoma After Anogenital Warts in Adults Living With HIV

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):283-289. doi:10.1001/jamadermatol.2020.5252

This cohort study assesses the risk of developing anal carcinoma in adults living with HIV who have a history of anogenital warts.

Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):290-295. doi:10.1001/jamadermatol.2020.5347

This cohort study examines the prevalence of acne in transgender individuals initiating masculinizing hormone therapy.

Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):296-300. doi:10.1001/jamadermatol.2020.5468

This cohort study assesses the change in the rates of potassium level monitoring from 2008 to 2018 by clinicians overall and stratified by dermatologists, internists, nurse practitioners, and physician assistants in healthy young women treated for acne with spironolactone.

Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Abstract Full Text
open access
JAMA Dermatol. 2021;157(3):301-306. doi:10.1001/jamadermatol.2020.5595

This cohort study reports pregnancy outcomes observed among women enrolled in the Psoriasis Longitudinal Assessment and Registry.

Surgical Interventions for Patients With Vitiligo: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):307-316. doi:10.1001/jamadermatol.2020.5756

This systematic review and meta-analysis investigates the treatment response of different surgical modalities in patients with vitiligo.

Brief Report

Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome

Abstract Full Text
JAMA Dermatol. 2021;157(3):317-321. doi:10.1001/jamadermatol.2020.4901

This case series assesses the preliminary efficacy and tolerability of brentuximab vedotin for Sézary syndrome.

Changes in Use of Radiotherapy Among Dermatologists From 2013 to 2017

Abstract Full Text
JAMA Dermatol. 2021;157(3):322-325. doi:10.1001/jamadermatol.2020.4931

This cross-sectional study examines changes in the use of radiotherapy, including superficial radiotherapy and electronic brachytherapy, over time by dermatologists.

Special Communication

The Role of Dermatologists in the Early HIV/AIDS Epidemic: A Historical Review for the 40th Anniversary of HIV/AIDS

Abstract Full Text
has audio
JAMA Dermatol. 2021;157(3):326-329. doi:10.1001/jamadermatol.2020.5545

This Special Communication reviews dermatology’s role in the investigation and treatment of HIV/AIDS over the past 40 years.

Review

Shared Decision-making in Dermatology: A Scoping Review

Abstract Full Text
JAMA Dermatol. 2021;157(3):330-337. doi:10.1001/jamadermatol.2020.5362

This scoping review discusses the use of shared decision-making between patients and physicians in dermatology practice.

Images in Dermatology

Levamisole-Induced Vasculopathy

Abstract Full Text
JAMA Dermatol. 2021;157(3):338. doi:10.1001/jamadermatol.2020.4011

This case report describes man in his 40s who was a long-term cocaine user who presented with rapidly progressive painful skin lesions and malaise.

White Piedra

Abstract Full Text
JAMA Dermatol. 2021;157(3):339. doi:10.1001/jamadermatol.2020.4266

This case report describes white and tubular concretions of proteinaceous materials that were tightly adherent to the hair shaft.

JAMA Dermatology Clinicopathological Challenge

Follicular Papules in a Linear Distribution on a Child’s Face

Abstract Full Text
JAMA Dermatol. 2021;157(3):340-341. doi:10.1001/jamadermatol.2020.5588

A girl younger than 2 years presented with a 1-year history of slightly pruritic lesions involving her face. What is your diagnosis?

Hypertrichotic Plaque in a 17-Month-Old Boy

Abstract Full Text
JAMA Dermatol. 2021;157(3):342-343. doi:10.1001/jamadermatol.2020.5665

A 17-month-old boy presents with a 15 × 5-cm indurated plaque with hypertrichosis on the left lower back in addition to blue-gray patches on the back and right hip and a small café au lait macule on the right lower back. The patient’s history is significant for dermal melanocytosis of the back and hip, increased head circumference, and expressive language delay. What is your diagnosis?

JAMA Dermatology Patient Page

Allergic Contact Dermatitis

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):364. doi:10.1001/jamadermatol.2020.5639

This Patient Page describes the symptoms, possible causes, and treatment of allergic contact dermatitis.

Research Letter

Moderate-to-Severe Acne and Mental Health Symptoms in Transmasculine Persons Who Have Received Testosterone

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):344-346. doi:10.1001/jamadermatol.2020.5353

This survey study examines the association between acne and mental health outcomes for transmasculine persons who have received testosterone.

Hair Removal for Patients Undergoing Feminizing Surgeries in Oregon’s Medicaid Program

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):346-348. doi:10.1001/jamadermatol.2020.5419

This cohort study assessed the use of preoperative hair removal among transgender individuals assigned male sex at birth enrolled in Oregon’s Medicaid program and their clinicians.

Incidence and Factors Associated With Androgenetic Alopecia Among Transgender and Gender-Diverse Patients Treated With Masculinizing Hormone Therapy

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):348-349. doi:10.1001/jamadermatol.2020.5475

This cohort study examines the proportion of transgender and gender-diverse individuals patients receiving masculinizing hormone therapy who developed androgenetic alopecia.

Postoperative Radiotherapy for Cutaneous Squamous Cell Carcinoma in Patients With Microscopic Residual Disease

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):349-352. doi:10.1001/jamadermatol.2020.4828

This case series assesses data from patients with microscopic residual disease to examine postoperative radiotherapy outcomes.

Observation

Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis

Abstract Full Text
JAMA Dermatol. 2021;157(3):352-353. doi:10.1001/jamadermatol.2020.4555

This case report describes opaque trachyonychia of all fingernails.

Treatment of Grover Disease With Dupilumab

Abstract Full Text
JAMA Dermatol. 2021;157(3):353-356. doi:10.1001/jamadermatol.2020.5097

This case report describes 3 patients with focal acantholytic dyskeratosis.

Comment & Response

Photodynamic Therapy and Medicare Expenditures

Abstract Full Text
JAMA Dermatol. 2021;157(3):356-357. doi:10.1001/jamadermatol.2020.5422

Photodynamic Therapy and Medicare Expenditures—Reply

Abstract Full Text
JAMA Dermatol. 2021;157(3):357. doi:10.1001/jamadermatol.2020.4657

Pharmacogenomics of Fluoropyrimidines—A Personalized Approach for Treating and Preventing Keratinocyte Carcinomas

Abstract Full Text
JAMA Dermatol. 2021;157(3):357-358. doi:10.1001/jamadermatol.2020.5542

Pharmacogenomics of Fluoropyrimidines—a Personalized Approach for Treating and Preventing Keratinocyte Carcinomas—Reply

Abstract Full Text
JAMA Dermatol. 2021;157(3):358. doi:10.1001/jamadermatol.2020.5246
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2021;157(3):264. doi:10.1001/jamadermatol.2020.3866
×